ENCell Co (XKRX:456070) EBIT per Share : ₩-505.75 (TTM As of Dec. 2023)

View and export this data going back to 2024. Start your Free Trial

What is ENCell Co EBIT per Share?

ENCell Co's EBIT per Share for the three months ended in Dec. 2023 was ₩-505.75. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-505.75.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for ENCell Co's EBIT per Share or its related term are showing as below:

XKRX:456070's 3-Year EBIT Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 5.9
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

ENCell Co's EBIT for the three months ended in Dec. 2023 was ₩-3,125 Mil.

ENCell Co EBIT per Share Historical Data

The historical data trend for ENCell Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ENCell Co EBIT per Share Chart

ENCell Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EBIT per Share

-33,150.47

-25,357.54

-8,925.38

-505.75

ENCell Co Quarterly Data
	Dec20	Dec21	Dec22	Dec23
EBIT per Share	-33,150.47	-25,357.54	-8,925.38	-505.75

ENCell Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

ENCell Co's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-3124.53	/	6.178
=	-505.75

ENCell Co's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-3124.53	/	6.178
=	-505.75

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-505.75

ENCell Co (XKRX:456070) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

ENCell Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of ENCell Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

ENCell Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ENCell Co Ltd (XKRX:456070) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

701 Yeongdong-daero, 11th floor, Gangnam-gu, Seoul, KOR

Website

http://www.encellinc.com

ENCell Co Ltd is a biopharmaceutical company. The company is engaged in conducting biopharmaceutical contract development and manufacturing (CDMO) service business and cell, gene therapy new drug development business for rare/incurable muscle diseases such as Charcot-Marie-Tooth disease, Duchenne muscular dystrophy, and sarcopenia.

ENCell Co Headlines

No Headlines